Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Family carer's experience of a delirium resource (PREDICT) to support care partnerships with healthcare professionals: A qualitative study.

Geriatric nursing (New York, N.Y.)·2026
Same author

The Michigan Sibling Immunity Birth Study (M-SIBS): Study design protocol for a unique food allergy birth cohort.

The journal of allergy and clinical immunology. Global·2026
Same author

Stoichiometrically Defined Antibody-DNA Conjugates for Quantitative Super-Resolution Imaging.

Nano letters·2026
Same author

A Scoping Review of Technology/Digital Support Tools for Informal Mental Health Carers: Impacts on Well being and Experience.

Community mental health journal·2026
Same author

Comparison of baseline TEWL values in OFC positive and negative patients.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

A p53 peptide mucosal vaccine induces cellular and humoral immunity and anti-tumor effects in a murine colorectal cancer model.

Cancer gene therapy·2026

Related Experiment Video

Updated: Jun 17, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Dendrimer-based nanoparticles for cancer therapy.

James R Baker1

  • 1Division of Allergy and Clinical Immunology, Michigan Nanotechnology Institute for Medicine and Biological Sciences, Ann Arbor, MI 48109-5648, USA. jbakerjr@umich.edu

Hematology. American Society of Hematology. Education Program
|December 17, 2009
PubMed
Summary

Dendrimers, a type of nanoparticle, show promise for revolutionizing cancer diagnosis and therapy. These nanotherapeutics offer improved imaging contrast agents and targeted drug delivery, enhancing treatment efficacy and safety.

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Related Experiment Videos

Last Updated: Jun 17, 2026

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier
07:53

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery
09:09

Synthesis of Aptamer-PEI-g-PEG Modified Gold Nanoparticles Loaded with Doxorubicin for Targeted Drug Delivery

Published on: June 23, 2020

Area of Science:

  • Nanotechnology
  • Oncology
  • Drug Delivery

Background:

  • Nanoparticles, specifically dendrimers, are emerging as key components in future therapeutic strategies.
  • The field of oncology is exploring novel applications for dendrimer-based nanotherapeutics.

Purpose of the Study:

  • To explore the fundamentals of dendrimer research in cancer diagnosis and therapy.
  • To evaluate the advantages of dendrimer-based therapeutics over conventional cancer drugs.

Main Methods:

  • Utilizing dendrimers as advanced contrast agents for enhanced diagnostic imaging (e.g., MRI), potentially targeted to cancer cells.
  • Employing dendrimers for targeted drug delivery, akin to a "Trojan horse" strategy, delivering anti-metabolites via tumor-specific nutrients.
  • Investigating dendrimer applications in photodynamic therapy, boron neutron capture therapy, and gene therapy for cancer.

Main Results:

  • Dendrimers can improve cancer diagnosis through targeted contrast agents for imaging techniques like MRI.
  • Dendrimers enhance the safety and efficacy of various cancer therapies.
  • Targeted delivery systems using dendrimers show potential for improved anti-cancer drug action.

Conclusions:

  • Dendrimer-based nanotherapeutics represent a significant advancement in oncology, offering improved diagnostic and therapeutic capabilities.
  • Further research and evaluation are crucial to fully realize the potential of dendrimers in revolutionizing cancer treatment.